Tools
Small Bowel Bleeding
Introduction
Gastrointestinal bleed is the most common diagnosis for GI-related inpatient admissions. Amongst the GI bleeds, about 50% are due to upper GI tract bleeds, 40% are due to lower GI tract bleeds, and about 5% to 10% are due to lesions in the small bowel.[1] The small bowel is the part of the GI tract between the ligament of Treitz and the ileocecal valve. Small bowel bleeding can be divided into overt or occult.[2]
Patients are considered to have overt bleeding when they have visible bleeding, either melena or hematochezia. The bleeding is considered occult when there is no gross bleeding, but signs and symptoms of anemia, including fatigue, dyspnea, or palpitations, are present. Small bowel bleeding poses a significant diagnostic challenge for gastroenterologists. The clinical significance lies in the fact that most small bowel causes go undetected because the small bowel is long and hard to reach and therefore difficult to evaluate.[3][4]
Etiology
Register For Free And Read The Full Article
Search engine and full access to all medical articles- 10 free questions in your specialty
- Free CME/CE Activities
- Free daily question in your email
- Save favorite articles to your dashboard
- Emails offering discounts
Learn more about a Subscription to StatPearls Point-of-Care
Etiology
The etiology of small bowel bleeding is extensive, and it varies with the patient's age.[5] Patients with age less than 40 are likely to have Dieulafoy lesion, neoplasm, Meckel diverticulum, or inflammatory bowel disease. In patients older than 40 years, angiodysplasia, Dieulafoy lesion, or NSAID-related ulcers are more likely.[6]
The most common cause of small bowel GI bleed is a vascular lesion. 30-40% of bleeding in the small bowel is caused by abnormal vessels in the small bowel, with angiodysplasia being the most common.[7] The vascular lesions may also be induced by nonsteroidal anti-inflammatory drugs (NSAIDs). The other causes include tumors, aorto-enteric fistula, medications, small intestine ulcers, and non-specific enteritis.[8]
Epidemiology
The prevalence of small bowel lesions has been estimated to be 5 to 10% in patients presenting with GI bleeding.[9] The studies have shown neoplasms to be the most common cause in Asian countries. In contrast, angiectasias were the leading cause in Western countries.[10] The type of lesion causing the bleed is dependent on the age of the patient. Crohn disease and Meckel diverticulum are more likely in the younger population, less than 40 years. Angiectasia and vascular lesions are mostly seen in the older population, greater than 40 years. Neoplasms and Dieulafoy lesions are seen equally among the younger and the older age groups.[11] There is no role of gender, and prevalence is equal in males and females. There is limited data available regarding small bowel findings among different ethnicities.
History and Physical
The patient's initial assessment with small bowel bleeding must include a good clinical history and physical examination. A small bowel bleed can present with varying presentations. It can be overt or occult bleeding. It can be a massive bleed presenting as shock or could be persistent bleeding leading to anemia. A detailed history can help in guiding towards a specific diagnosis.[12][13] It should include the following,
- Medical history (valvular heart disease, liver cirrhosis, chronic pancreatitis, radiation therapy)
- Surgical history (liver transplantation, abdominal aortic aneurysm repair, bowel resection)
- Medications (NSAIDs, anticoagulants, antiplatelets)
- Family history (Hereditary hemorrhagic telangiectasia, Peutz Jegher syndrome)
- Social history (alcohol intake)
The physical examination findings can help to narrow down the diagnosis. The findings of telangiectasia in HHT (hereditary hemorrhagic telangiectasia), spider angioma, and caput medusa in portal hypertension, pigmented lips in Peutz Jegher's syndrome can be found on examination.[14]
The history of chronic pancreatitis can lead to the diagnosis of rare causes like Haemosuccus pancreaticus.[15] Additional causes like a history of worms in the stools should be sought in people, especially in tropical regions.
Evaluation
Small intestinal bleeding is a rare cause of gastrointestinal bleeding. The diagnosis is challenging for the physician and involves much time and financial burden. The initial step in evaluation is endoscopy. However, with the advancement in novel endoscopic and radiological techniques, diagnosis and treatment have evolved. The latest diagnostic modalities including, capsule endoscopy and deep enteroscopy, have made it possible to go farther into the small bowel, helping to visualize and treat the lesions.[13] There is no single diagnostic study with high sensitivity and specificity that could be used, thus making the diagnosis challenging.
Endoscopy
Endoscopy is the first diagnostic study. A regular endoscope helps evaluate the esophagus, stomach, and duodenum. It is capable of providing a good view up to the first part of the small bowel. It has the advantage of being diagnostic and therapeutic at the same time. The endoscopist would be able to perform an intervention if any lesion is found.[16]
Imaging Studies
CT enterography involves the use of oral contrast solution. It allows for the detailed inspection of the small bowel lining and looks for any lesions.[17] The CT scan's advantage is finding the bleeding source out of the standard endoscope's reach. The primary limitations are the inability to do any intervention even if an abnormality is seen. Another imaging modality, CT angiography, helps in localizing the lesion and embolizing it. CT angiography's disadvantage is that the lesion should be actively bleeding, and the rate of bleeding should be 0.3 to 0.5 mL/min.[18] The nuclear studies involving the scintigraphy study with tagged RBC scans are more sensitive than CT angiography. It can detect bleeding at a rate of 0.1 mL/min.[19]
Capsule Endoscopy
Capsule endoscopy is used when the endoscopy studies have failed to find any bleeding source. The camera is attached to a device that is about the size of a pill. It helps visualize the entire GI tract as it takes images until it is finally eliminated in the stool.[20]
The capsule study is generally safe. It has the advantage of visualizing the entire GI tract and localize the bleeding source. The disadvantages include the inability to take biopsies and do any intervention. In patients with prior history of abdominal surgeries, the capsule can rarely get stuck inside the GI tract. It may require surgery if the capsule gets stuck. Despite these limitations, capsule endoscopy is the second line if the standard endoscope fails to diagnose any bleeding source.[21]
Push Enteroscopy
Push enteroscopy or double-balloon enteroscopy is a new advancement to standard endoscopes. They have been used when the lesion is farther down in the small bowel and not seen with the standard endoscopes. It uses two balloons, which can help the scope be pushed farther into the small bowel.[22] It is possible to see the lesions, as far as the ileum, depending upon the performer's expertise. The advantage is the ability to treat, take biopsies and mark the area with the tattoo. Studies have shown that the enteroscope has identified the bleeding source in about 74% of patients and treated about 60% to 70%.[23]
Intraoperative Enteroscopy
Surgery may be required in cases when no diagnosis could be found. Intraoperative enteroscopy is done under general anesthesia by a team comprising of gastroenterologists and surgeons. The scope is advanced through the incision in the small bowel. The advantage is that it allows to treat the cause of bleeding, AVMs, or to remove masses or polyps. It has been shown to treat about 70% of the patients effectively.[24]
Treatment / Management
The management options for small bowel bleeding involve conservative, radiological, pharmacologic, endoscopic, and surgical methods. The choice depends upon the indications, availability, and expertise.[25] The occult bleeding is treated usually in the outpatient setting. It involves endoscopic and imaging studies to localize the lesion and treating it appropriately. The overt bleeding is usually an emergency and warrants inpatient admission. It requires fluid resuscitation, localization of the lesion with angiography and scintigraphy. Enteroscopy could be used for therapeutic management once the lesion has been identified.
The pharmacological therapies are used when the lesions are extensive and cannot be treated with invasive therapies. The different pharmacological options include hormonal therapies (estrogen and progesterone) and octreotide.[26] Octreotide is effective in various studies. These drugs act via multiple mechanisms involving decreased splanchnic blood flow, improved platelet aggregation, and angiogenesis inhibition.[27] Thalidomide, a VEGF inhibitor, acts by inhibiting angiogenesis. It has been used for refractory and recurrent blood loss secondary to angiodysplasia.[28] Studies have shown that the patients who took this drug had decreased requirement of blood transfusions.(B3)
The endoscopic and interventional radiographic techniques are used for treating vascular lesions. The choice of the appropriate therapy depends upon the availability and expertise. The options include electrocoagulation, laser photocoagulation, argon plasma coagulation (APC), injection sclerotherapy, hemoclip placement, endoscopic band ligation, and/or a combination of these.[29][30] Endoscopic hemostatic methods are used in cases of ectopic varices. Interventional radiological techniques using embolization are done when the endoscopic treatment is not successful.[31] Surgery is the last resort and is done in patients with recurrent bleeding and failed endoscopic treatments.(A1)
Differential Diagnosis
- Inflammatory bowel disease
- Meckel's diverticulum
- GI stromal cell tumor
- Polypoid lesions
- Dieulafoy lesions
- Angioectasia
- NSAID ulcers
- Haemobilia
- Haemosuccus pancreaticus
- Aorto-enteric fistula
Prognosis
There are limited studies regarding the prognosis after a small bowel bleed. The in-hospital mortality is low, < 5%. Most of the complications occur in patients with comorbid conditions.[32] Death usually occurs due to the worsening of underlying co-morbidities. Increasing age has been shown to increase mortality.[33] The mortality rate was higher in men than women. The negative prognostic factors involve hypovolemia, transfusion requirement, and underlying coagulopathies. Long-term follow-up studies are limited for small bowel bleeding.[34]
Complications
- Heart failure
- Respiratory distress
- Myocardial infarction
- Infection
- Shock
- Death
Deterrence and Patient Education
Patients should be educated about the manifestations of GI bleed. They should be made aware of various presentations such as melena, signs of anemia such as fatigue, palpitations, and dyspnea. Counseling should be provided to limit the use of nonsteroidal anti-inflammatory drugs and to quit smoking and alcohol.[35] When concerned about any changes in bowel habits or having any overt or occult GI bleed, they should follow up with the local physician. The patients should be educated about the concerning scenarios, such as hypotension or confusion. They should be made aware of the need for emergent management in these conditions.
Enhancing Healthcare Team Outcomes
Patients usually present to the primary physician with anemia-like symptoms and to the emergency with hematochezia. The management usually involves an interprofessional approach involving surgeons, gastroenterologists, radiologists, and intensivists, supported by nursing staff with training in gastrointestinal disorders.[36] Depending upon the presentation, they might need ICU monitoring. Some patients may require fluid resuscitation and blood transfusions. Multiple imaging studies might be required before the diagnosis is made.[37] Coordinating all these activities with an interprofessional team approach will drive better patient outcomes. [Level 5]
CT enterography and CT angiography are useful in localizing the lesion. Endoscopic management involving EGD and push enteroscopy are helpful diagnostic and therapeutic modalities. Surgery is usually the last resort, and some refractory patients may need it for diagnosis and treatment.[38] The outcomes depend upon the patient's age, underlying co-morbidities, hemodynamic stability, and the need for emergent surgery.
References
Lau WY, Fan ST, Wong SH, Wong KP, Poon GP, Chu KW, Yip WC, Wong KK. Preoperative and intraoperative localisation of gastrointestinal bleeding of obscure origin. Gut. 1987 Jul:28(7):869-77 [PubMed PMID: 3498667]
Katz LB. The role of surgery in occult gastrointestinal bleeding. Seminars in gastrointestinal disease. 1999 Apr:10(2):78-81 [PubMed PMID: 10361899]
Level 3 (low-level) evidenceBrar HS, Aloysius MM, Shah NJ. Cameron Lesions. StatPearls. 2024 Jan:(): [PubMed PMID: 33620853]
Chetcuti Zammit S, Sidhu R. Small bowel bleeding: cause and the role of endoscopy and medical therapy. Current opinion in gastroenterology. 2018 May:34(3):165-174. doi: 10.1097/MOG.0000000000000429. Epub [PubMed PMID: 29521682]
Level 3 (low-level) evidenceRaju GS, Gerson L, Das A, Lewis B, American Gastroenterological Association. American Gastroenterological Association (AGA) Institute technical review on obscure gastrointestinal bleeding. Gastroenterology. 2007 Nov:133(5):1697-717 [PubMed PMID: 17983812]
Zhang BL, Chen CX, Li YM. Capsule endoscopy examination identifies different leading causes of obscure gastrointestinal bleeding in patients of different ages. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology. 2012 Jun:23(3):220-5 [PubMed PMID: 22798110]
Level 2 (mid-level) evidenceOhmiya N, Yano T, Yamamoto H, Arakawa D, Nakamura M, Honda W, Itoh A, Hirooka Y, Niwa Y, Maeda O, Ando T, Yao T, Matsui T, Iida M, Tanaka S, Chiba T, Sakamoto C, Sugano K, Goto H. Diagnosis and treatment of obscure GI bleeding at double balloon endoscopy. Gastrointestinal endoscopy. 2007 Sep:66(3 Suppl):S72-7 [PubMed PMID: 17709039]
Sun B, Rajan E, Cheng S, Shen R, Zhang C, Zhang S, Wu Y, Zhong J. Diagnostic yield and therapeutic impact of double-balloon enteroscopy in a large cohort of patients with obscure gastrointestinal bleeding. The American journal of gastroenterology. 2006 Sep:101(9):2011-5 [PubMed PMID: 16848814]
Level 2 (mid-level) evidenceMitsui K, Tanaka S, Yamamoto H, Kobayashi T, Ehara A, Yano T, Goto H, Nakase H, Tanaka S, Matsui T, Iida M, Sugano K, Sakamoto C. Role of double-balloon endoscopy in the diagnosis of small-bowel tumors: the first Japanese multicenter study. Gastrointestinal endoscopy. 2009 Sep:70(3):498-504. doi: 10.1016/j.gie.2008.12.242. Epub 2009 Jun 24 [PubMed PMID: 19555947]
Level 2 (mid-level) evidencePasha SF, Leighton JA, Das A, Harrison ME, Decker GA, Fleischer DE, Sharma VK. Double-balloon enteroscopy and capsule endoscopy have comparable diagnostic yield in small-bowel disease: a meta-analysis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2008 Jun:6(6):671-6. doi: 10.1016/j.cgh.2008.01.005. Epub 2008 Mar 20 [PubMed PMID: 18356113]
Level 1 (high-level) evidenceCangemi DJ, Patel MK, Gomez V, Cangemi JR, Stark ME, Lukens FJ. Small bowel tumors discovered during double-balloon enteroscopy: analysis of a large prospectively collected single-center database. Journal of clinical gastroenterology. 2013 Oct:47(9):769-72. doi: 10.1097/MCG.0b013e318281a44e. Epub [PubMed PMID: 23426457]
Level 2 (mid-level) evidenceKuo JR, Pasha SF, Leighton JA. The Clinician's Guide to Suspected Small Bowel Bleeding. The American journal of gastroenterology. 2019 Apr:114(4):591-598. doi: 10.1038/s41395-018-0424-x. Epub [PubMed PMID: 30747768]
Gunjan D, Sharma V, Rana SS, Bhasin DK. Small bowel bleeding: a comprehensive review. Gastroenterology report. 2014 Nov:2(4):262-75. doi: 10.1093/gastro/gou025. Epub 2014 May 29 [PubMed PMID: 24874805]
Amin SK, Antunes C. Lower Gastrointestinal Bleeding. StatPearls. 2022 Jan:(): [PubMed PMID: 28846221]
Han B, Song ZF, Sun B. Hemosuccus pancreaticus: a rare cause of gastrointestinal bleeding. Hepatobiliary & pancreatic diseases international : HBPD INT. 2012 Oct:11(5):479-88 [PubMed PMID: 23060392]
Spiller RC, Parkins RA. Recurrent gastrointestinal bleeding of obscure origin: report of 17 cases and a guide to logical management. The British journal of surgery. 1983 Aug:70(8):489-93 [PubMed PMID: 6603248]
Level 3 (low-level) evidenceGhonge NP, Aggarwal B, Gothi R. CT enterography: state-of-the-art CT technique for small bowel imaging. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology. 2013 May:32(3):152-62. doi: 10.1007/s12664-013-0307-4. Epub 2013 Mar 10 [PubMed PMID: 23475544]
Geffroy Y, Rodallec MH, Boulay-Coletta I, Jullès MC, Ridereau-Zins C, Zins M. Multidetector CT angiography in acute gastrointestinal bleeding: why, when, and how. Radiographics : a review publication of the Radiological Society of North America, Inc. 2011 May-Jun:31(3):E35-46 [PubMed PMID: 21721196]
Mellinger JD, Bittner JG 4th, Edwards MA, Bates W, Williams HT. Imaging of gastrointestinal bleeding. The Surgical clinics of North America. 2011 Feb:91(1):93-108. doi: 10.1016/j.suc.2010.10.014. Epub [PubMed PMID: 21184902]
Level 3 (low-level) evidenceGerson LB, Fidler JL, Cave DR, Leighton JA. ACG Clinical Guideline: Diagnosis and Management of Small Bowel Bleeding. The American journal of gastroenterology. 2015 Sep:110(9):1265-87; quiz 1288. doi: 10.1038/ajg.2015.246. Epub 2015 Aug 25 [PubMed PMID: 26303132]
Liao Z, Gao R, Xu C, Li ZS. Indications and detection, completion, and retention rates of small-bowel capsule endoscopy: a systematic review. Gastrointestinal endoscopy. 2010 Feb:71(2):280-6. doi: 10.1016/j.gie.2009.09.031. Epub [PubMed PMID: 20152309]
Level 2 (mid-level) evidenceTsujikawa T, Saitoh Y, Andoh A, Imaeda H, Hata K, Minematsu H, Senoh K, Hayafuji K, Ogawa A, Nakahara T, Sasaki M, Fujiyama Y. Novel single-balloon enteroscopy for diagnosis and treatment of the small intestine: preliminary experiences. Endoscopy. 2008 Jan:40(1):11-5 [PubMed PMID: 18058613]
Level 2 (mid-level) evidenceYamamoto H, Sekine Y, Sato Y, Higashizawa T, Miyata T, Iino S, Ido K, Sugano K. Total enteroscopy with a nonsurgical steerable double-balloon method. Gastrointestinal endoscopy. 2001 Feb:53(2):216-20 [PubMed PMID: 11174299]
Monsanto P, Almeida N, Lérias C, Figueiredo P, Gouveia H, Sofia C. Is there still a role for intraoperative enteroscopy in patients with obscure gastrointestinal bleeding? Revista espanola de enfermedades digestivas. 2012 Apr:104(4):190-6 [PubMed PMID: 22537367]
Level 2 (mid-level) evidenceVan de Bruaene C, Hindryckx P, Van de Bruaene L, De Looze D. Bleeding Lesion of the Small Bowel: an Extensive Update Leaving No Stone Unturned. Current gastroenterology reports. 2018 Mar 7:20(2):5. doi: 10.1007/s11894-018-0610-4. Epub 2018 Mar 7 [PubMed PMID: 29516183]
Watanabe T, Sugimori S, Kameda N, Machida H, Okazaki H, Tanigawa T, Watanabe K, Tominaga K, Fujiwara Y, Oshitani N, Higuchi K, Arakawa T. Small bowel injury by low-dose enteric-coated aspirin and treatment with misoprostol: a pilot study. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2008 Nov:6(11):1279-82. doi: 10.1016/j.cgh.2008.06.021. Epub [PubMed PMID: 18995219]
Level 3 (low-level) evidenceRossini FP, Arrigoni A, Pennazio M. Octreotide in the treatment of bleeding due to angiodysplasia of the small intestine. The American journal of gastroenterology. 1993 Sep:88(9):1424-7 [PubMed PMID: 8362842]
Hvid-Jensen HS, Poulsen SH, Agnholt JS. Severe Gastrointestinal Bleeding in a Patient With Subvalvular Aortic Stenosis Treated With Thalidomide and Octreotide: Bridging to Transcoronary Ablation of Septal Hypertrophy. Journal of clinical medicine research. 2015 Nov:7(11):907-10. doi: 10.14740/jocmr2321w. Epub 2015 Sep 25 [PubMed PMID: 26491506]
Suzuki R, Irisawa A, Hikichi T, Shibukawa G, Takagi T, Wakatsuki T, Imamura H, Takahashi Y, Sato A, Sato M, Ikeda T, Tasaki K, Obara K, Ohira H. Hemorrhagic duodenal varices treated successfully with endoscopic injection sclerotherapy using cyanoacrylate and ethanolamine-oleate: a case report. Surgical laparoscopy, endoscopy & percutaneous techniques. 2009 Dec:19(6):e233-6. doi: 10.1097/SLE.0b013e3181c4e883. Epub [PubMed PMID: 20027076]
Level 3 (low-level) evidenceLienhart I, Lesne A, Couchonnal E, Rivory J, Sosa-Valencia L, Ponchon T, Pioche M. Massive duodenal variceal bleed: endoscopic ultrasonography of ruptured varix and successful endoscopic clipping treatment. Endoscopy. 2016:48 Suppl 1 UCTN():E80-1. doi: 10.1055/s-0042-102959. Epub 2016 Mar 7 [PubMed PMID: 26951472]
Leung WK, Ho SS, Suen BY, Lai LH, Yu S, Ng EK, Ng SS, Chiu PW, Sung JJ, Chan FK, Lau JY. Capsule endoscopy or angiography in patients with acute overt obscure gastrointestinal bleeding: a prospective randomized study with long-term follow-up. The American journal of gastroenterology. 2012 Sep:107(9):1370-6. doi: 10.1038/ajg.2012.212. Epub 2012 Jul 24 [PubMed PMID: 22825363]
Level 1 (high-level) evidenceStrate LL, Ayanian JZ, Kotler G, Syngal S. Risk factors for mortality in lower intestinal bleeding. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2008 Sep:6(9):1004-10; quiz 955-. doi: 10.1016/j.cgh.2008.03.021. Epub 2008 Jun 16 [PubMed PMID: 18558513]
Level 2 (mid-level) evidenceLi L, Chen C, Li Y, Zhang B. The role of capsule endoscopy in the diagnosis and treatment of obscure gastrointestinal bleeding in older individuals. European journal of gastroenterology & hepatology. 2016 Dec:28(12):1425-1430 [PubMed PMID: 27603298]
Shinozaki S, Yamamoto H, Yano T, Sunada K, Miyata T, Hayashi Y, Arashiro M, Sugano K. Long-term outcome of patients with obscure gastrointestinal bleeding investigated by double-balloon endoscopy. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2010 Feb:8(2):151-8. doi: 10.1016/j.cgh.2009.10.023. Epub 2009 Oct 30 [PubMed PMID: 19879968]
Level 2 (mid-level) evidenceDiGregorio AM, Alvey H. Gastrointestinal Bleeding. StatPearls. 2024 Jan:(): [PubMed PMID: 30725976]
Fok KY, Murugesan JR, Maher R, Engel A. Management of per rectal bleeding is resource intensive. ANZ journal of surgery. 2019 Apr:89(4):E113-E116. doi: 10.1111/ans.15149. Epub 2019 Mar 18 [PubMed PMID: 30887672]
Kherad O, Restellini S, Martel M, Sey M, Murphy MF, Oakland K, Barkun A, Jairath V. Outcomes following restrictive or liberal red blood cell transfusion in patients with lower gastrointestinal bleeding. Alimentary pharmacology & therapeutics. 2019 Apr:49(7):919-925. doi: 10.1111/apt.15158. Epub 2019 Feb 25 [PubMed PMID: 30805962]
Samaha E, Rahmi G, Landi B, Lorenceau-Savale C, Malamut G, Canard JM, Bloch F, Jian R, Chatellier G, Cellier C. Long-term outcome of patients treated with double balloon enteroscopy for small bowel vascular lesions. The American journal of gastroenterology. 2012 Feb:107(2):240-6. doi: 10.1038/ajg.2011.325. Epub 2011 Sep 27 [PubMed PMID: 21946281]
Level 2 (mid-level) evidence